Validation of the Turkish Parkinsons Disease Dyskinesia Scale PDYS-26 for Parkinsons Patients with Dyskinesia

What this Trial Is About

This research aims to validate and test the reliability of the Turkish version of the Parkinsons Disease Dyskinesia Scale PDYS-26 for patients with idiopathic Parkinsons disease. Dyskinesia, which involves involuntary muscle movements, is a common motor complication in Parkinsons disease and can affect daily activities. The study evaluates how well this scale measures dyskinesia impact in Turkish-speaking patients and compares it with other assessments like the Tampa Kinesiophobia Scale, Mini BesTest, Activity Specific Balance Safety Scale, and Parkinsons Disease Questionnaire-39. Participants diagnosed with idiopathic Parkinsons disease who have a dyskinesia score of 1 or higher on the Unified Parkinsons Disease Rating Scale UPDRS will be involved. The PDYS-26 scale will be translated into Turkish using a back-translation method and finalized with expert approval. Patients will complete the adapted scale and other related assessments to determine its validity and reliability in the Turkish population. Participants will be assessed at baseline Day 1 and again seven days later Day 8 using the PDYS-26. The study includes evaluations through various questionnaires and scales to measure dyskinesia severity, balance, fear of movement, and quality of life. The research team will monitor the participants responses to ensure the scales effectiveness and relevance for use in clinical settings with Turkish Parkinsons patients.

Reliability and Validity Study of the Turkish Version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)